Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raban Jeger

Showing results (21-30 of 103) with videos related to

Pageof 11
Sort By:
Innovations (Philadelphia, Pa.)|September 25, 2014
Single-center experience and short-term outcome with the JenaValve: a second-generation transapical transcatheter aortic valve implantation deviceOliver Reuthebuch, Devdas Thomas Inderbitzin, Florian Rüter, et al.
Circulation. Cardiovascular Interventions|April 5, 2019
Twenty-Year Trends in the Incidence and Outcome of Cardiogenic Shock in AMIS Plus RegistryLukas Hunziker, Dragana Radovanovic, Raban Jeger, et al.
International Journal of Cardiology|January 28, 2014
Acute multivessel revascularization improves 1-year outcome in ST-elevation myocardial infarction: a nationwide study cohort from the AMIS Plus registryRaban Jeger, Milosz Jaguszewski, Brahmajee N Nallamothu, et al.
BMC Cardiovascular Disorders|October 18, 2019
Do ultrathin strut bare-metal stents with passive coating improve efficacy in large coronary arteries? Insights from the randomized, multicenter BASKET-PROVE trialsKim Wadt Hansen, Raban Jeger, Rikke Sørensen, et al.
European Heart Journal|February 21, 2025
Individual patient data meta-analysis of paclitaxel-coated balloons vs. drug-eluting stents for small-vessel coronary artery disease: the ANDROMEDA studySimone Fezzi, Daniele Giacoppo, Gregor Fahrni, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 4, 2020
Four-year mortality in women and men after transfemoral transcatheter aortic valve implantation using the SAPIEN 3Giuseppe Tarantini, Helmut Baumgartner, Derk Frank, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 8, 2011
The Angio-Seal™ femoral closure device allows immediate ambulation after coronary angiography and percutaneous coronary interventionAnders Hvelplund, Raban Jeger, Remo Osterwalder, et al.
Swiss Medical Weekly|April 8, 2020
Coronary and structural heart interventions in Switzerland 2018Thomas Nestelberger, Raphael Twerenbold, Stéphane Cook, et al.
Revista Espanola De Cardiologia (English Ed.)|April 15, 2018
New-onset or Pre-existing Atrial Fibrillation in Acute Coronary Syndromes: Two Distinct Phenomena With a Similar PrognosisLuigi Biasco, Dragana Radovanovic, Marco Moccetti, et al.
Open Heart|June 21, 2019
Drug-eluting stents in large coronary vessels improve both safety and efficacy compared with bare-metal stents in women: a pooled analysis of the BASKET-PROVE I and II trialsLouise Hougesen Bjerking, Kim Wadt Hansen, Rikke Sørensen, et al.
Pageof 11

Showing results (21-30 of 103) with videos related to

Sort By:
Pageof 11
Innovations (Philadelphia, Pa.)|September 25, 2014
Single-center experience and short-term outcome with the JenaValve: a second-generation transapical transcatheter aortic valve implantation deviceOliver Reuthebuch, Devdas Thomas Inderbitzin, Florian Rüter, et al.
Circulation. Cardiovascular Interventions|April 5, 2019
Twenty-Year Trends in the Incidence and Outcome of Cardiogenic Shock in AMIS Plus RegistryLukas Hunziker, Dragana Radovanovic, Raban Jeger, et al.
International Journal of Cardiology|January 28, 2014
Acute multivessel revascularization improves 1-year outcome in ST-elevation myocardial infarction: a nationwide study cohort from the AMIS Plus registryRaban Jeger, Milosz Jaguszewski, Brahmajee N Nallamothu, et al.
BMC Cardiovascular Disorders|October 18, 2019
Do ultrathin strut bare-metal stents with passive coating improve efficacy in large coronary arteries? Insights from the randomized, multicenter BASKET-PROVE trialsKim Wadt Hansen, Raban Jeger, Rikke Sørensen, et al.
European Heart Journal|February 21, 2025
Individual patient data meta-analysis of paclitaxel-coated balloons vs. drug-eluting stents for small-vessel coronary artery disease: the ANDROMEDA studySimone Fezzi, Daniele Giacoppo, Gregor Fahrni, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 4, 2020
Four-year mortality in women and men after transfemoral transcatheter aortic valve implantation using the SAPIEN 3Giuseppe Tarantini, Helmut Baumgartner, Derk Frank, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 8, 2011
The Angio-Seal™ femoral closure device allows immediate ambulation after coronary angiography and percutaneous coronary interventionAnders Hvelplund, Raban Jeger, Remo Osterwalder, et al.
Swiss Medical Weekly|April 8, 2020
Coronary and structural heart interventions in Switzerland 2018Thomas Nestelberger, Raphael Twerenbold, Stéphane Cook, et al.
Revista Espanola De Cardiologia (English Ed.)|April 15, 2018
New-onset or Pre-existing Atrial Fibrillation in Acute Coronary Syndromes: Two Distinct Phenomena With a Similar PrognosisLuigi Biasco, Dragana Radovanovic, Marco Moccetti, et al.
Open Heart|June 21, 2019
Drug-eluting stents in large coronary vessels improve both safety and efficacy compared with bare-metal stents in women: a pooled analysis of the BASKET-PROVE I and II trialsLouise Hougesen Bjerking, Kim Wadt Hansen, Rikke Sørensen, et al.
Pageof 11